Related Experiment Video
Updated: Jun 15, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding
1Department of Pulmonary Medicine, Hospital de Gran Canaria 'Dr Negrín', Las Palmas de Gran Canaria University, Las Palmas de Gran Canaria, Spain. jcamlun@gobiernodecanarias.org
Multidrug-resistant tuberculosis (MDR-TB) is a growing global health threat. Effective national TB programs and identifying high-risk patients are key to controlling the MDR-TB epidemic.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- The multidrug-resistant tuberculosis (MDR-TB) epidemic is a significant global health challenge with an estimated 500,000 cases worldwide.
- Understanding the burden and trends of MDR-TB is crucial for developing effective control strategies.
Purpose of the Study:
- To analyze the factors contributing to the MDR-TB epidemic.
- To identify populations at risk and guide case-finding efforts.
- To evaluate the impact of national TB programs on MDR-TB trends.
Main Methods:
- Review of current estimates of MDR-TB burden.
- Analysis of risk factors for drug resistance in tuberculosis.
- Evaluation of epidemiological data and national TB program effectiveness.
Main Results:
- Risk factors for resistance are categorized into community-level selection and patient-specific vulnerabilities.
- Poor treatment practices and control program implementation significantly impact the epidemiological situation.
- National TB programs efficiently utilizing existing drugs can reverse MDR-TB trends.
- Treatment failures with first-line regimens and contact with MDR-TB cases are associated with high resistance rates.
Conclusions:
- Recognizing epidemic drivers and at-risk populations is essential for targeted case-finding.
- Prioritizing patients with a history of TB treatment and contacts of MDR-TB cases is recommended for effective management.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
